APPLICATIONS PUBLISHED 13 AUGUST 2003

Published: 1-Jan-2004

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Bdellosomes
    Bernina Biosystems 1333806*

  • Extended release erythromycin derivatives
    Advancis Pharmaceuticals 1333807*

  • Electroprocessed compsn used in drug delivery and cell encapsulation
    Virginia Commonweath University Intelectual Property Foundation 1333808*

  • Multi-component antioxidant compounds, pharmaceutical compsns containing same, and their use for reducing or preventing oxidative stress
    Yissum Research and Development Company of the Hebrew University of Jerusalem 1333809*

  • Oral doage self-emulsifying formulations of pyranone protease inhibitors
    Boehringer Ingelheim Pharmaceuticals 1333810*

  • Liposomal formulation of mitoxantrone
    Neopharm 1333811*

  • Microgranules based on active principle and method for making same
    Ethypharm 1333812*

  • Process for the preparation of an oral delivery device
    SmithKline Beecham plc; SmithKline Beecham Corp 1333813*

  • Parenterally administrable microparticles
    Jagotec 1333814*

  • Process for producing microparticles
    Jagotec 1333815*

  • Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
    Flamel Technologies 1333816*

  • Film for active ingredients dermal and transdermal administration
    Laboratorio Italiano Biochimico Farmaceutico 1333817*

  • Titratable dosage transdermal delivery system
    Euro-Celtique 1333818*

  • Inhalative solution formulation containing a tiotropium salt
    Boehringer Ingelheim Pharma 1333819*

  • A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
    Aventis Pharma 1333820*

  • Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists
    Merck Patent 1333821*

  • Treatment of diseases with adamantine derivatives
    Tinnitus Forschungs- und Entwicklungs 1333822*

  • Therapeutic use of aerosolised S-nitrosoglutathione in cystic fibrosis
    Duke Technology; The University of Virginia Patent Foundation 1333823*

  • Treatment of sexual dysfunction
    Warner-Lambert 1333824*

  • Method for enhanced delivery of oxybutynin and compsns thereof
    Theramax 1333825*

  • Phase transfer catalysed glycosidation of an indolocarbazole
    Merck; Banyu Pharmaceuticals 1333826*

  • Oestrogen receptor modulators
    Merck 1333827*

  • Prevention of development of dyskinesias
    Orion 1333828*

  • Treatment of sexual dysfunction using bombesin antagonists
    Warner-Lambert 1333829*

  • Novel medicament compsns based on anticholinergics and corticosteroids
    Boehringer Ingelheim Pharma 1333830*

  • Aza- and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors
    Merck 1333831*

  • Novel uses of combined 5HT1A agonists and serotonin reuptake inhibitors
    Merck Patent 1333832*

  • Novel compounds
    SmithKline Beecham 1333833*

  • Anti-inflammation agents
    Tularik 1333834*

  • The use of selective noradrenalin reuptake inhibitors for the treatment of tension-type headache
    Head Explorer 1333835*

  • Cephalosporin antibiotics and prodrugs thereof
    Essential Therapeutics 1333836*

  • You may also like